Background: Pruritus is a distressing symptom of cholestatic, inflammatory, and malignant liver diseases. It is a common symptom in many biliary and cholestatic disorders such as primary biliary cirrhosis (PBC). Several mechanisms are generally accepted as possible explanations to the underlying basis of itch. However, the exact pathophysiology of pruritus in liver diseases remains unclear. The cutaneous and central neurobiology of pruritus is complex and underlies a regulation of variable mechanisms. At present, not all mechanisms including neuromediators and receptors are known. Objective: Our objective is to evaluate whether the expression pattern of NGF and its receptor TrK A has a role in pruritus in a group of Egyptian cirrhotic patients. Patients and Methods: Forty Patients with liver cirrhosis were enrolled in the study depending on clinical evidence of stigmata of chronic liver disease (e.g. jaundice, ascites, palmar erythema, spider naevi, etc.) and ultrasonographic features of liver cirrhosis (e.g. coarse echo texture, shrunken liver, etc.). Patients were divided into two groups. Group (1): included 20 patients cirrhotic patients without pruritus. Group (2): included 20 patients cirrhotic patients with pruritus. A group of age and sex matched healthy twenty volunteers as a control. Results: After evaluation of histopathological using hematoxylin and eosin stained sections (H&E) was done. There was positive correlation between NGF protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.876, p value ≤ 0.001). Also there was positive correlation between TrK A protein expression and severity of pruritus in cirrhotic patients with pruritus (r = 0.44, p value ≤ 0.05). Conclusions: We report, for the first time, role of these proteins (NGF/TrK A) in the mechanism of pruritus in cirrhotic patients and may provide a potential target for new treatment of pruritus in cirrhotic.
References
[1]
Ständer, S., Weisshaar, E., Mettang, T., Szepietowski, J.C., Carstens, E., Ikoma, A., et al. (2007) Clinical Classification of Itch: A Position Paper of the International Forum for the Study of Itch. Acta Dermato-Venereologica, 87, 291-294. https://doi.org/10.2340/00015555-0305
[2]
Sommer, F., Hensen, P., böckenholt, B., Metze, D., Luger, T.A. and Ständer, S. (2007) Underlying Diseases and, Co-Factors in Patients with Severe Chronic Pruritus: A 3-Year Retrospective Study. Acta Dermato-Venereologica, 87, 510-516. https://doi.org/10.2340/00015555-0320
[3]
Weisshaar, E., Apfelbacher, C., Jager, G., Zimmermann, E., Bruckner, T., Diepgen, T.L. and Gollnick, H. (2006) Pruritus as a Leadingsymptom: Clinical Characteristics and Quality of Life Ingerman and Ugandan Patients. British Journal of Dermatology, 155, 957-964. https://doi.org/10.1111/j.1365-2133.2006.07430.x
[4]
Bergasa, N.V. (2011) The Itch of Liver Disease. Seminars in Cutaneous Medicine and Surgery, 30, 8-93. https://doi.org/10.1016/j.sder.2011.04.009
[5]
Zein, C.O. and Lindor, K.D. (2010) Latest and Emerging Therapies for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis. Current Gastroenterology Reports, 12, 13-22. https://doi.org/10.1007/s11894-009-0079-2
[6]
Patel, K.N. and Dong, X. (2011) Itch: Cells, Molecules, and Circuits. ACS Chemical Neuroscience, 2, 17-25.
[7]
Oude Elferink, R.P., Kremer, A.E., Martens, J.J. and Beuers, U.H. (2011) The Molecular Mechanism of Cholestatic Pruritus. Digestive Diseases, 29, 66-71. https://doi.org/10.1159/000324131
[8]
Nockher, W.A. and Renz, H. (2006) Neurotrophins in Allergic Diseases: From Neuronal Growth Factor to Intercellular Signaling Molecules. Journal of Allergy and Clinical Immunology, 117, 583-589. https://doi.org/10.1016/j.jaci.2005.11.049
[9]
Dou, Y., Hagstromer, L. and Emtestam, L. (2006) Increased Nerve Growth Factor and Its Receptors in Atopic Dermatitis: An Immunohistochemical Study. Archives of Dermatological Research, 298, 31-37. https://doi.org/10.1007/s00403-006-0657-1
[10]
Botchkarev, V., Peters, E. and Paus, R. (2004) Epithelial Growth Control by Neurotrophins: Leads and Lessons from the Hair Follicle. Progress in Brain Research, 146, 493-513. https://doi.org/10.1016/S0079-6123(03)46031-7
[11]
Pincelli, C. and Yaar, M. (1997) Nerve Growth Factor: Its Significance in Cutaneous Biology. Journal of Investigative Dermatology Symposium Proceedings, 2, 61-68. https://doi.org/10.1038/jidsymp.1997.8
[12]
Papoiu, A.D.P., Wang, H., Nattkemper, L., et al. (2011) A Study of Serum Concentrations and Dermal Levels of NGF in Atopic Dermatitis and Healthy Subjects. Neuropeptides, 45, 417-422. https://doi.org/10.1016/j.npep.2011.07.008
[13]
Pugh, R., Murray Lyon, I., Dawson, J., Pietroni, M. and Williams, R. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. British Journal of Surgery, 60, 646-649. https://doi.org/10.1002/bjs.1800600817
[14]
Elman, S., Hynan, L., Gabriel, V. and Mayo, M. (2010) The 5-D Itch Scale: A New Measure of Pruritus. British Journal of Dermatology, 162, 587-593. https://doi.org/10.1111/j.1365-2133.2009.09586.x
[15]
Lindor, K., Gershwin, M., Poupon, R., Kaplan, M. and Bergasa, N. (2009) Primary Biliary Cirrhosis. Hepatology, 50, 291-308. https://doi.org/10.1002/hep.22906
[16]
Jones, D. (2012) Pathogenesis of Cholestatic Itch: Old Questions, New Answers and Future Opportunities. Hepatology, 56, 1194-1196. https://doi.org/10.1002/hep.25847
[17]
Raap, U. and Kapp, A. (2005) Neuroimmunological Findings in Allergic Skin Diseases. Current Opinion in Allergy and Clinical Immunology, 5, 419-424. https://doi.org/10.1097/01.all.0000183111.78558.4d
[18]
Michalak, A., Hanc, M., Fatyga, A. and Skublewska, A. (2011) Pruritus in Liver Disease—Pathogenesis and Treatment. Journal of Pre-Clinical and Clinical Research, 5, 47-49.
[19]
Desphande, V., Burd, E., Aardema, K. and Moonka, D. (2001) High Levels of Hepatitis C Virus RNA in Native Livers Correlate with the Development of Cholestatic Hepatitis in Liver Allografts and a Poor Outcome. Liver Transplantation, 7, 118-124. https://doi.org/10.1053/jlts.2001.21278
[20]
Zekri, A., Bahnassy, A., Mohamed, W., Alam El-Din, H. and Shousha, H. (2013) Dynamic Interplay between CXCL Levels in Chronic Hepatitis C Patients Treated by Interferon. Virology Journal, 10, 218. https://doi.org/10.1186/1743-422X-10-218
